Dystrophinopathy Phenotypes and Modifying Factors in DMD Exon 45–55 Deletion

OBJECTIVE: Duchenne muscular dystrophy (DMD) exon 45–55 deletion (del45–55) has been postulated as a model that could treat up to 60% of DMD patients, but the associated clinical variability and complications require clarification. We aimed to understand the phenotypes and potential modifying factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Poyatos‐García, Javier, Martí, Pilar, Liquori, Alessandro, Muelas, Nuria, Pitarch, Inmaculada, Martinez‐Dolz, Luis, Rodríguez, Benjamin, Gonzalez‐Quereda, Lidia, Damiá, Maria, Aller, Elena, Selva‐Gimenez, Marta, Vilchez, Roger, Diaz‐Manera, Jordi, Alonso‐Pérez, Jorge, Barcena, José Eulalio, Jauregui, Amaia, Gámez, Josep, Aladrén, Jesus Angel, Fernández, Ariadna, Montolio, Marisol, Azorin, Inmaculada, Hervas, David, Casasús, Ana, Nieto, Marisa, Gallano, Pia, Sevilla, Teresa, Vilchez, Juan Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825930/
https://www.ncbi.nlm.nih.gov/pubmed/35897138
http://dx.doi.org/10.1002/ana.26461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825930/
https://www.ncbi.nlm.nih.gov/pubmed/35897138
http://dx.doi.org/10.1002/ana.26461

Ejemplares similares